Livelsberger Financial Advisory’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Livelsberger Financial Advisory's INFI Position: Q1 2024 in Review

Livelsberger Financial Advisory sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2024, closing a stake of 200 shares — an estimated $1 sold.

Livelsberger Financial Advisory first reported a position in INFI in Q4 2023 and held it in 1 quarter. The position peaked at $1 in Q4 2023. 1 fund tracked by Wall St. Rank holds INFI as of Q1 2024.

• Livelsberger Financial Advisory reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2024 after selling out during the quarter.
• Livelsberger Financial Advisory sold 200 Infinity Pharmaceuticals, Inc. shares in Q1 2024, an estimated $1.
• Livelsberger Financial Advisory first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2023 and held it in 1 quarter.
• Livelsberger Financial Advisory's Infinity Pharmaceuticals, Inc. position peaked at $1 in Q4 2023.
• 1 fund tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2024.

Based on Livelsberger Financial Advisory's 13F filing for Q1 2024, filed 22 May 2024.